AF
Therapeutic Areas
Gland Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Enoxaparin Sodium Injection | Anticoagulation / Deep Vein Thrombosis | Approved |
| Cefazolin Injection | Antibiotic / Surgical Prophylaxis | Approved |
| Heparin Sodium Injection | Anticoagulation | Approved |
| Biosimilar Pipeline (Confidential) | Oncology, Autoimmune Diseases | Development |
| CDMO Pipeline (Confidential Molecules) | Various (Oncology, Critical Care) | Phase 1 to Commercial |
| Complex Generics (Peptides/Hormones) | Diabetes, Endocrinology | Pre-clinical to Filing |
Leadership Team at Gland Pharma
SS
Srinivas Sadu
Managing Director & Chief Executive Officer
GS
G. S. Murthy
Chief Financial Officer
DR
Dr. Ravi Kumar
Chief Operating Officer
VS
V. S. S. Murthy
Chief Human Resources Officer
SK
S. K. Narayan
President - Global Business Development
DG
Dr. G. V. Prasad
Non-Executive Director (Chairman)
JD
Jin Deyong
Non-Executive Director
GQ
Gong Qing
Non-Executive Director
DV
Dr. V. S. R. Krishnan
Independent Director
D(
Dr. (Mrs.) V. Mohan
Independent Director